The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways

Recently, we found that sMEK1 effectively regulates pro-apoptotic activity when combined with a traditional chemotherapeutic drug. Therefore, combinational therapeutic strategies targeting critical molecular and cellular mechanisms are urgently required. In this present work, we evaluated whether sM...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Boh-Ram, Yoon, Kyungsil, Byun, Hyun-Jung, Seo, Seung Hee, Lee, Seung-Hoon, Rho, Seung Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171649/
https://www.ncbi.nlm.nih.gov/pubmed/25153728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171649/
https://www.ncbi.nlm.nih.gov/pubmed/25153728

Ejemplares similares